A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : FDG-PET

Search Conditions:
Search Keyword : FDG-PET
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: FDG-PET
Appearance Frequency: 2141 time(s)
Long forms: 30

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
fluorodeoxyglucose positron emission tomography
(2061 times)
Neoplasms
(453 times)
CT (397 times)
MRI (231 times)
SUV (136 times)
1990 Quantifying interictal metabolic activity in human temporal lobe epilepsy.
18F-fluorodeoxyglucose PET
(35 times)
Neurology
(14 times)
AD (6 times)
CT (3 times)
ADNI (2 times)
1995 The use of PET in evaluating patients with primary brain tumours: is it useful?
FDG-positron emission tomography
(16 times)
Neoplasms
(6 times)
CT (5 times)
FDG (5 times)
MRI (3 times)
1998 [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
18-fluorodeoxyglucose PET imaging
(2 times)
Neoplasms
(1 time)
PET (2 times)
2011 Metabolic positron emission tomography imaging in cancer detection and therapy response.
follow-up LDCT, 2-(18F)fluoro-2-deoxy-D glucose positron emission tomography
(2 times)
Thoracic Neoplasms
(1 time)
FNAB (2 times)
LDCT (2 times)
ICRP (1 time)
2012 Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT.
18-fluorine-fluorodesoxyglucose positron emission tomography including low-dose CT
(1 time)
Heart Diseases
(1 time)
MDCT (1 time)
PHV (1 time)
TTE/TEE (1 time)
2016 Novel imaging strategies for the detection of prosthetic heart valve obstruction and endocarditis.
18-Fluoro-2-Deoxy-D-Glucose positron emission
(1 time)
Endocrinology
(1 time)
ACTH-PPC (1 time)
CD (1 time)
ERT (1 time)
2000 ACTH-producing pituitary cancer: experience at the King Faisal Specialist Hospital & Research Centre.
18F-2-deoxy-2-fluoro-D-glucose PET
(1 time)
Neoplasms
(1 time)
PET (1 time)
2005 A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma.
18F-FDG positron emission tomography/computed tomography
(1 time)
Neoplasms
(1 time)
DMFS (1 time)
DWI (1 time)
PFS (1 time)
2019 Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
10  18F-fluorodeoxyglucose positron emission tomography positron emission tomography
(1 time)
Neurology
(1 time)
CT (1 time)
DAI (1 time)
MRI (1 time)
2019 Cerebral Glucose Metabolism in Patients with Chronic Mental and Cognitive Sequelae after a Single Blunt Mild Traumatic Brain Injury without Visible Brain Lesions.
11  F 18-labeled positron emission tomography
(1 time)
Nervous System Diseases
(1 time)
AD (1 time)
HOMA-IR (1 time)
WRAP (1 time)
2015 Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
12  F-deoxy-glucose PET
(1 time)
Neurology
(1 time)
BPF (1 time)
VBM (1 time)
2010 Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
13  facilitate image analysis, most recent 2-(18F)fluoro-2-deoxy-d-glucose PET
(1 time)
Neurology
(1 time)
AD (1 time)
MCI (1 time)
ROIs (1 time)
2005 Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
14  factors, we employed an integrated approach, using resting-state functional
(1 time)
Biomedical Research
(1 time)
CD (1 time)
DTI (1 time)
SLE-associated (1 time)
2019 Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.
15  False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography
(1 time)
Prostatic Neoplasms
(1 time)
--- 2013 False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses.
16  FDG-positron emission computed tomography
(1 time)
Brain
(1 time)
PLEDs (1 time)
SE (1 time)
1994 Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are a manifestation of partial status epilepticus.
17  FDG-positron emission CT
(1 time)
Neurology
(1 time)
fMRI (1 time)
MEPs (1 time)
MRI (1 time)
2005 [A patient with focal dystonia induced by golf and presenting a decrease in activity of cerebral motor cortex on task].
18  fluorine-18-FDG positron emission tomography
(1 time)
General Surgery
(1 time)
--- 2006 The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer.
19  fluorine-18-fluorodeoxyglucose activity distribution from positron emission tomography
(1 time)
Biophysics
(1 time)
SPECT (1 time)
2004 Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
20  fluoro-D-glucose PET
(1 time)
Diagnostic Imaging
(1 time)
2DG (1 time)
AD (1 time)
ROI (1 time)
2010 Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.
21  Fluoro-D-Glucose positron emission imaging
(1 time)
Diagnostic Imaging
(1 time)
CS (1 time)
HD (1 time)
NHL (1 time)
2002 2-deoxy-2-[F-18]fluoro-D-glucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma.
22  fluorodeoxyglucose PET scan
(1 time)
Pulmonary Medicine
(1 time)
--- 2003 Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids.
23  fluorodeoxyglucose uptake
(1 time)
Dementia
(1 time)
AD (1 time)
ASL-MRI (1 time)
2012 Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
24  fluorodeoxyglucose uptake as assessed by positron emission tomography
(1 time)
Cardiology
(1 time)
MRI (1 time)
1995 Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
25  fluorodeoxyglucose uptake on PET
(1 time)
Nervous System Diseases
(1 time)
AD (1 time)
ADNI (1 time)
CSF (1 time)
2018 The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer's Disease.
26  Fluorodeoxyglucose-traced PET
(1 time)
PET (1 time)
2016 Integrating Information from FDG - and Amyloid PET for Detecting Different Types of Dementia in Older Persons. A Case-series Study.
27  follow-up Positron Emission Tomography with ((18)F)fluoro-2-deoxy-D-glucose
(1 time)
Gastroenterology
(1 time)
CT (1 time)
2007 Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response.
28  following prostatectomy, imaged with 2-(18F)fluoro-2-deoxyglucose positron emission tomography
(1 time)
Neoplasms
(1 time)
PSA (1 time)
2005 2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
29  Functional imaging such as positron emission tomography and computed tomography
(1 time)
Hematology
(1 time)
HAART (1 time)
HL (1 time)
2012 Hodgkin lymphoma in patients with HIV infection: a review.
30  functional imaging with 2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography
(1 time)
Medicine
(1 time)
--- 2016 Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging.